Kite Pharma to Participate in September 2016 Investor Conferences

Back

SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite Pharma, Inc., (Nasdaq:KITE) today announced that management will participate in a panel at the 11^th Annual Citi Biotech Conference and a fireside chat discussion at the Morgan Stanley Global Healthcare Conference.

11^th Annual Citi Biotech Conference
		o Date: Wednesday, September 7, 2016
		o Time: 2:00 PM Eastern Time
		o Location: Boston, MA

Morgan Stanley Global Healthcare Conference
		o Date: Tuesday, September 13, 2016
		o Time: 1:30 PM Eastern Time
		o Location: New York, NY

A live audio webcast of each event will be available on the Investors section of Kite's website, www.kitepharma.com. A replay of each webcast will be available on the website for approximately 30 days.

About Kite Pharma

Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160831006261/en/

Kite Pharma
Greg Mann
VP, Investor Relations
gmann@kitepharma.com
or
For Media:
inVentiv Health
David Polk, 310-309-1029
david.polk@inventivhealth.com

Source: Kite Pharma, Inc.

News Provided by Acquire Media